These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 20056593
21. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS. Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258 [Abstract] [Full Text] [Related]
22. MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials? Coats AJ. Int J Cardiol; 2002 Jan; 82(1):1-5. PubMed ID: 11786150 [Abstract] [Full Text] [Related]
23. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. Cuoco FA, Spencer WH, Fernandes VL, Nielsen CD, Nagueh S, Sturdivant JL, Leman RB, Wharton JM, Gold MR. J Am Coll Cardiol; 2008 Nov 18; 52(21):1718-23. PubMed ID: 19007692 [Abstract] [Full Text] [Related]
24. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines. Foley PW, Addison CE, Whinney SB, Patel K, Cunningham D, Frenneaux MP, Leyva F. Pacing Clin Electrophysiol; 2009 Mar 18; 32 Suppl 1():S131-4. PubMed ID: 19250076 [Abstract] [Full Text] [Related]
25. Immediate Risk-Stratification Improves Survival (IRIS): study protocol. Steinbeck G, Andresen D, Senges J, Hoffmann E, Seidl K, Brachmann J, IRIS Investigators as Joint Study of the German University Hospitals and German Society of Leading Cardiological Hospital Physicians (ALKK). Europace; 2004 Sep 18; 6(5):392-9. PubMed ID: 15294263 [Abstract] [Full Text] [Related]
26. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy. Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML. Am J Cardiol; 2010 Jan 01; 105(1):105-11. PubMed ID: 20102900 [Abstract] [Full Text] [Related]
27. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death. Stockburger M, Krebs A, Nitardy A, Habedank D, Celebi O, Knaus T, Dietz R. Pacing Clin Electrophysiol; 2009 Mar 01; 32 Suppl 1():S16-20. PubMed ID: 19250084 [Abstract] [Full Text] [Related]
28. The Italian Implantable Cardioverter-Defibrillator Registry. A survey of the national activity during the years 2001-2003. Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM. Ital Heart J; 2005 Mar 01; 6(3):272-80. PubMed ID: 15875520 [Abstract] [Full Text] [Related]
29. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L. Rev Esp Cardiol; 2006 Jun 01; 59(6):537-44. PubMed ID: 16790196 [Abstract] [Full Text] [Related]
30. Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Zaman S, Sivagangabalan G, Narayan A, Thiagalingam A, Ross DL, Kovoor P. Circulation; 2009 Jul 21; 120(3):194-200. PubMed ID: 19581496 [Abstract] [Full Text] [Related]
31. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score. van Rees JB, Borleffs CJ, van Welsenes GH, van der Velde ET, Bax JJ, van Erven L, Putter H, van der Bom JG, Schalij MJ. Heart; 2012 Jun 21; 98(11):872-7. PubMed ID: 22581736 [Abstract] [Full Text] [Related]
35. Use of implantable cardioverter defibrillators for primary prevention in the community: do women and men equally meet trial enrollment criteria? Daugherty SL, Peterson PN, Wang Y, Curtis JP, Heidenreich PA, Lindenfeld J, Vidaillet HJ, Masoudi FA, NCDR. Am Heart J; 2009 Aug 21; 158(2):224-9. PubMed ID: 19619698 [Abstract] [Full Text] [Related]
37. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias. Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ. Eur Heart J; 2007 Jul 21; 28(14):1746-9. PubMed ID: 17283003 [Abstract] [Full Text] [Related]
39. Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death. Kreuz J, Balta O, Liliegren N, Mellert F, Esmailzadeh B, Nickenig G, Schwab JO. Pacing Clin Electrophysiol; 2007 Jan 21; 30 Suppl 1():S125-7. PubMed ID: 17302687 [Abstract] [Full Text] [Related]
40. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators. Sredniawa B, Mazurek M, Lenarczyk R, Kowalski O, Kowalczyk J, Kalarus Z. Future Cardiol; 2010 May 21; 6(3):315-23. PubMed ID: 20462338 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]